✦ LIBER ✦

Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia

✍ Scribed by Hagop M. Kantarjian; Elihu H. Estey; William Plunkett; Michael J. Keating; Ronald S. Walters; Stephen Iacoboni; Kenneth B. McCredie; Emil J. Freireich

Book ID: 115680916
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 947 KB
Volume: 81
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(86)90287-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase-II study of treatment of refractor

Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrine

✍ U. Jehn; V. Heinemann 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 261 KB

High antileukemic activity of sequential

High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias : Results of a clinical Phase II study

✍ Wolfgang Kern; Eberhard Schleyer; Michael Unterhalt; Bernhard Wörmann; Thomas Bü 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

Department of Heremission whereas 5 patients (23%) succumbed to early death and 3 patients (14%) matology and Oncology, Go ¨ttingen, Germany. did not respond. Blood counts recovered at a median of 33.5 days after the start 2 Westfa ¨lische Wilhelms University, Department of treatment and complete r

Treatment of refractory acute myeloid le

Treatment of refractory acute myeloid leukemia with high-dose cytosine arabinoside and mitoxantrone in combination

✍ W. Hiddemann; H. Kreutzmann; W.D. Ludwig; H.C. Aul; R. Donhuijsen-Ant; E. Lengfe 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Phase I Trial of FLAGM with High Doses o

Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia: Study of the Japan Adult Leukemia Study Group (JALSG)

✍ Shuichi Miyawaki; Yasukazu Kawai; Akihiro Takeshita; Norio Komatsu; Noriko Usui; 📂 Article 📅 2007 🏛 Carden Jennings Publishing 🌐 English ⚖ 101 KB

Phase I study of high-dose cytosine arab

Phase I study of high-dose cytosine arabinoside and etoposide in patients with advanced malignancies

✍ Bayard L. Powell; Hyman B. Muss; Robert L. Capizzi; Mary E. Caponera; Douglas R. 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 273 KB

Idarubicin plus attenuated high-dose cyt

Idarubicin plus attenuated high-dose cytosine arabinoside in the treatment of relapsed and refractory acute leukemia

✍ L. Cavanna; M. Di Stasi; F. Fornari; G. Civardi; G. Sbolli; M. Moretto; L. Busca 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB